Correlation Between Sarepta Therapeutics and MetLife

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and MetLife at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and MetLife into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and MetLife, you can compare the effects of market volatilities on Sarepta Therapeutics and MetLife and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of MetLife. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and MetLife.

Diversification Opportunities for Sarepta Therapeutics and MetLife

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sarepta and MetLife is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and MetLife in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MetLife and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with MetLife. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MetLife has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and MetLife go up and down completely randomly.

Pair Corralation between Sarepta Therapeutics and MetLife

Given the investment horizon of 90 days Sarepta Therapeutics is expected to under-perform the MetLife. In addition to that, Sarepta Therapeutics is 3.27 times more volatile than MetLife. It trades about -0.17 of its total potential returns per unit of risk. MetLife is currently generating about 0.46 per unit of volatility. If you would invest  6,916  in MetLife on December 29, 2023 and sell it today you would earn a total of  495.00  from holding MetLife or generate 7.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sarepta Therapeutics  vs.  MetLife

 Performance 
       Timeline  
Sarepta Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Low
 
High
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Sarepta Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Sarepta Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
MetLife 

Risk-Adjusted Performance

13 of 100

 
Low
 
High
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MetLife are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, MetLife unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sarepta Therapeutics and MetLife Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sarepta Therapeutics and MetLife

The main advantage of trading using opposite Sarepta Therapeutics and MetLife positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, MetLife can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MetLife will offset losses from the drop in MetLife's long position.
The idea behind Sarepta Therapeutics and MetLife pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format